Ad5-EBOV

BIOLOGICAL2 trials

Sponsors

First Affiliated Hospital of Zhejiang University, Ministry of Health & Sanitation

Conditions

Ebola Ebola Virus DiseaseEbola Virus Disease

Phase 1

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

CompletedNCT02401373

First Affiliated Hospital of Zhejiang UniversityEbola Virus Disease

Start: 2015-03-31End: 2015-07-31Updated: 2015-07-16

Unknown Phase

A Phase II Clinical Trial to Evaluate the Recombinant Human Type 5 Adenovirus Vector Based Ebola Virus Disease Vaccine (Ad5-EBOV)

Active, not recruitingPACTR201509001259869

Ministry of Health & SanitationEbola Ebola Virus Disease

Start: 2015-10-01Target: 500Updated: 2026-08-03

Related Papers

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

2017-07-1423 citations

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.

2016-12-23158 citations